Cargando…
Minimising the Toxicities of First Line Hodgkin Lymphoma Treatment in the Modern Era
SIMPLE SUMMARY: Due to advances in chemotherapy and radiotherapy over recent decades, Hodgkin lymphoma is now a curable disease in the vast majority of younger patients. While treatment has become very effective, patients are burdened with significant short- and long-term side effects such as infect...
Autores principales: | Follows, Annabel M., Santarsieri, Anna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9655498/ https://www.ncbi.nlm.nih.gov/pubmed/36358808 http://dx.doi.org/10.3390/cancers14215390 |
Ejemplares similares
-
Relapsed mantle cell lymphoma presenting with lactic acidosis and hypoglycemia: A case report
por: Carson, Lucy, et al.
Publicado: (2023) -
Role of Radiotherapy in Modern Treatment of Hodgkin's Lymphoma
por: Yeoh, Kheng-Wei, et al.
Publicado: (2011) -
Recent advances in the first-line treatment of follicular non-Hodgkin lymphoma
por: Feugier, Pierre, et al.
Publicado: (2019) -
Incorporating Monoclonal Antibodies into the First-Line Treatment of Classical Hodgkin Lymphoma
por: Vassilakopoulos, Theodoros P., et al.
Publicado: (2023) -
Bendamustine-based therapy as first-line treatment for non-Hodgkin lymphoma
por: Gil, Lidia, et al.
Publicado: (2014)